Thomas Lauterbach

518 total citations
16 papers, 423 citations indexed

About

Thomas Lauterbach is a scholar working on Neurology, Pharmacology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Thomas Lauterbach has authored 16 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Neurology, 5 papers in Pharmacology and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Thomas Lauterbach's work include Parkinson's Disease Mechanisms and Treatments (5 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Estrogen and related hormone effects (4 papers). Thomas Lauterbach is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (5 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Estrogen and related hormone effects (4 papers). Thomas Lauterbach collaborates with scholars based in Germany, Austria and Belgium. Thomas Lauterbach's co-authors include Rolf W. Hartmann, Matthias Negri, Ursula Müller‐Vieira, Qingzhong Hu, Marc Bartels, Ulrike E. Hille, Carsten Jagusch, Carsten A. Vock, Reinhard Berkels and Detlef Geffken and has published in prestigious journals such as Neurology, Journal of Medicinal Chemistry and Epilepsia.

In The Last Decade

Thomas Lauterbach

15 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Lauterbach Germany 11 140 120 100 99 68 16 423
Bahman M. Sadeghpour Italy 12 50 0.4× 177 1.5× 77 0.8× 64 0.6× 160 2.4× 18 917
W. McNally United States 12 30 0.2× 104 0.9× 30 0.3× 18 0.2× 22 0.3× 16 438
Gamini Chandrasena United States 17 25 0.2× 260 2.2× 75 0.8× 55 0.6× 133 2.0× 32 577
B. Brooks Israel 12 41 0.3× 109 0.9× 21 0.2× 55 0.6× 9 0.1× 20 363
Gustaf Plym Forshell Sweden 11 25 0.2× 117 1.0× 40 0.4× 23 0.2× 58 0.9× 21 432
Jurema Schmidt Germany 15 70 0.5× 222 1.9× 49 0.5× 67 0.7× 83 1.2× 28 499
E.A. van Schaick Netherlands 13 18 0.1× 246 2.0× 54 0.5× 11 0.1× 37 0.5× 17 575
David E. Coutant United States 14 271 1.9× 63 0.5× 40 0.4× 118 1.2× 31 0.5× 33 491
S.L. Malcolm United Kingdom 11 13 0.1× 169 1.4× 55 0.6× 16 0.2× 25 0.4× 13 509
Mette Lund Pedersen Denmark 5 88 0.6× 192 1.6× 7 0.1× 16 0.2× 25 0.4× 9 399

Countries citing papers authored by Thomas Lauterbach

Since Specialization
Citations

This map shows the geographic impact of Thomas Lauterbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Lauterbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Lauterbach more than expected).

Fields of papers citing papers by Thomas Lauterbach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Lauterbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Lauterbach. The network helps show where Thomas Lauterbach may publish in the future.

Co-authorship network of co-authors of Thomas Lauterbach

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Lauterbach. A scholar is included among the top collaborators of Thomas Lauterbach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Lauterbach. Thomas Lauterbach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Weber, Yvonne, Gerhard Luef, Lars Joeres, et al.. (2019). Changes in drug load during lacosamide combination therapy: A noninterventional, observational study in German and Austrian clinical practice. Epilepsia Open. 4(3). 409–419. 7 indexed citations
2.
Timmermann, Lars, Christian Oehlwein, Gerhard Ransmayr, et al.. (2016). Patients’ perception of Parkinson’s disease-associated pain following initiation of rotigotine: a multicenter non-interventional study. Postgraduate Medicine. 129(1). 46–54. 9 indexed citations
3.
Sieb, Jörn Peter, Tobias Warnecke, Thomas Lauterbach, et al.. (2015). Caregivers’ and physicians’ attitudes to rotigotine transdermal patch versus oral Parkinson’s disease medication: an observational study. Current Medical Research and Opinion. 31(5). 967–974. 10 indexed citations
4.
5.
Woitalla, Dirk, Jan Kassubek, Lars Timmermann, et al.. (2014). Reduction of gastrointestinal symptoms in Parkinson's disease after a switch from oral therapy to rotigotine transdermal patch: A non-interventional prospective multicenter trial. Parkinsonism & Related Disorders. 21(3). 199–204. 24 indexed citations
6.
7.
Stiasny‐Kolster, Karin, Daniela Berg, Werner Hofmann, et al.. (2013). Effectiveness and tolerability of rotigotine transdermal patch for the treatment of restless legs syndrome in a routine clinical practice setting in Germany. Sleep Medicine. 14(6). 475–481. 11 indexed citations
8.
Martín‐Fontecha, Mar, Henar Vázquez‐Villa, José A. Ramos, et al.. (2013). New Serotonin 5-HT1A Receptor Agonists Endowed with Antinociceptive Activity in Vivo. Journal of Medicinal Chemistry. 56(20). 7851–7861. 26 indexed citations
9.
Hille, Ulrike E., Qingzhong Hu, Marc Bartels, et al.. (2009). Steroidogenic cytochrome P450 (CYP) enzymes as drug targets: Combining substructures of known CYP inhibitors leads to compounds with different inhibitory profile. Comptes Rendus Chimie. 12(10-11). 1117–1126. 20 indexed citations
10.
Hille, Ulrike E., Qingzhong Hu, Carsten A. Vock, et al.. (2009). Novel CYP17 inhibitors: Synthesis, biological evaluation, structure–activity relationships and modelling of methoxy- and hydroxy-substituted methyleneimidazolyl biphenyls. European Journal of Medicinal Chemistry. 44(7). 2765–2775. 57 indexed citations
11.
12.
Negri, Matthias, Qingzhong Hu, Ulrike E. Hille, et al.. (2008). CYP17 Inhibitors. Annulations of Additional Rings in Methylene Imidazole Substituted Biphenyls: Synthesis, Biological Evaluation and Molecular Modelling. Archiv der Pharmazie. 341(10). 597–609. 21 indexed citations
13.
Negri, Matthias, et al.. (2008). Synthesis, Biological Evaluation, and Molecular Modeling of Abiraterone Analogues: Novel CYP17 Inhibitors for the Treatment of Prostate Cancer. Journal of Medicinal Chemistry. 51(16). 5009–5018. 54 indexed citations
14.
15.
16.
Lauterbach, Thomas & Detlef Geffken. (1986). Cyclisierung von N‐substituierten 2,2‐Diarylglycolohydroxamsäuren zu 1,2‐Oxazetidin‐3‐onen. Liebigs Annalen der Chemie. 1986(8). 1478–1483. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bahman M. Sadeghpour Breakdown of academic impact, for papers by W. McNally Breakdown of academic impact, for papers by Gamini Chandrasena Breakdown of academic impact, for papers by B. Brooks Breakdown of academic impact, for papers by Gustaf Plym Forshell Breakdown of academic impact, for papers by Jurema Schmidt Breakdown of academic impact, for papers by E.A. van Schaick Breakdown of academic impact, for papers by David E. Coutant Breakdown of academic impact, for papers by S.L. Malcolm Breakdown of academic impact, for papers by Mette Lund Pedersen
Rankless by CCL
2026